Podoplanin antibody | D2-40
The function of podoplanin is yet to be fully elucidated; however, it may be involved in cell migration and/or actin cytoskeleton organization. It is required for normal lung cell proliferation and alveolus formation at birth, and can induce platelet aggregation (Ramirez et al, 2003, Wicki and Christofori, 2007).
Mouse anti human podoplanin antibody, clone D2-40 has been shown to be a sensitive and specific antibody for the detection of lymphatic endothelium in different malignancies, and is of value in the routine evaluation of lymphatic invasion in esophageal cancer (Kozłowski et al, 2011). Clone D2-40 was reported to be an excellent immunohistochemical marker of cutaneous Kaposi’s sarcomas, (Kahn et al, 2002), and may be useful in the differential diagnosis of epithelioid malignant mesothelioma versus adenocarcinoma (Chu et al, 2005).
- Target Species
- Product Form
- Purified IgG - liquid
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
0.1% Sodium Azide (NaN3) 1% Bovine Serum Albumin
- Resected tissue from dysgeminoma of the ovary
- Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- Guaranteed for 12 months from the date of despatch or until the date of expiry, whichever comes first. Please see label for expiry date.
- Q86YL7 Related reagents
- Entrez Gene
- PDPN Related reagents
- GO Terms
- GO:0000902 cell morphogenesis
- GO:0001946 lymphangiogenesis
- GO:0005887 integral to plasma membrane
- GO:0008360 regulation of cell shape
- GO:0031258 lamellipodium membrane
- GO:0031527 filopodium membrane
- GO:0031528 microvillus membrane
- GO:0032587 ruffle membrane
- For research purposes only
Applications of Podoplanin antibody
|Application Name||Verified||Min Dilution||Max Dilution|
|Immunohistology - Frozen||1/10||1/40|
|Immunohistology - Paraffin||1/10||1/40|
- This product does not require protein digestion pre-treatment of paraffin sections. This product does not require antigen retrieval using heat treatment prior to staining of paraffin sections.
- Histology Positive Control Tissue
- Human lymph node
Secondary Antibodies Available
Product Specific References
References for Podoplanin antibody
Marks, A. et al. (1999) Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours.
Br J Cancer. 80 (3-4): 569-78.
Wu, H.M. et al. (2013) Expression of podoplanin in salivary gland adenoid cystic carcinoma and its association with distant metastasis and clinical outcomes.
Mol Med Rep. 6: 271-4.
Takagi, S. et al. (2013) Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.
PLoS One. 8: e73609.
Sonne, S.B. et al. (2006) Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours.
Virchows Arch. 449 (2): 200-6.
Heindl, L.M. et al (2010) Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension.
Ophthalmology 117(2): 334-42.
Ekwall, A.K. et al. (2011) The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritis.
Arthritis Res Ther. 13:R40.
Kozłowski, M. et al. (2011) Lymphatic vessel invasion detected by the endothelial lymphatic marker D2-40 (podoplanin) is predictive of regional lymph node status and an independent prognostic factor in patients with resected esophageal cancer.
Folia Histochem Cytobiol. 49: 90-7.
Rudzińska, M. et al. (2014) The role of podoplanin in the biology of differentiated thyroid cancers.
PLoS One. 9: e96541.
Bolzoni Villaret, A. et al. (2010) Immunostaining patterns of CD31 and podoplanin in previously untreated advanced oral/oropharyngeal cancer: prognostic implications.
Head Neck. 32: 786-92.
Heindl, L.M. et al. (2014) Lack of ciliary body lymphatics in iridociliary melanocytoma.
Graefes Arch Clin Exp Ophthalmol. 252: 169-71.
Heindl, L.M. et al. (2009) Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension.
Invest Ophthalmol Vis Sci. 50: 1988-95.
Heindl, L.M. et al. (2010) Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
Ophthalmology. 117: 334-42.
Wessel, J.M. et al. (2012) Invasion of lymphatic vessels into the eye after open globe injuries.
Invest Ophthalmol Vis Sci. 53: 3717-25.
Heindl, L.M. et al. (2011) Tumor-associated lymphangiogenesis in the development of conjunctival melanoma.
Invest Ophthalmol Vis Sci. 52: 7074-83.
Bolzoni Villaret, A. et al. (2013) Angiogenesis and lymphangiogenesis in early-stage laryngeal carcinoma: Prognostic implications.
Head Neck. 35: 1132-7.
Heindl, L.M. et al. (2011) Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Ophthalmology. 118: 2351-60.
Miyata, K. et al. (2014) Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment.
Cancer Med. 3 (6): 1595-604.
Choi, I.Y. et al. (2017) Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritis.
PLoS One. 12 (8): e0182751.